3-(1,3,2-Dioxaborinan-2-yl)pyridine → HCID 18007545, compound

HRID 844246Notes

Reaction equation

HRID 844246 reaction equation
Br[C:2]1[CH:10]=[C:9]2[C:5]([CH:6]=[CH:7][N:8]2[CH2:11][CH2:12][N:13]([CH2:16][CH3:17])[CH2:14][CH3:15])=[CH:4][CH:3]=1.B1([C:24]2[CH:29]=[CH:28][CH:27]=[N:26][CH:25]=2)OCCCO1>>[CH2:14]([N:13]([CH2:12][CH2:11][N:8]1[C:9]2[C:5](=[CH:4][CH:3]=[C:2]([C:24]3[CH:25]=[N:26][CH:27]=[CH:28][CH:29]=3)[CH:10]=2)[CH:6]=[CH:7]1)[CH2:16][CH3:17])[CH3:15]

Participants

3

Reactant 2

HCID 41980053-(1,3,2-Dioxaborinan-2-yl)pyridineHCID 18007607HCID 18007607, compound

Product 1

HCID 18007545HCID 18007545, compound

Procedure

(16.6 mg , 56%); from 6-bromo-1-(2-(N,N-diethylamino)ethyl) indole (30.7 mg, 0.101 mmol) and pyridine-3-boronic acid 1,3-propanediol cyclic ester (33.0 mg,0.202 mmol).

Sources & evidence

ORD record
ord-e3d3b93cd49e4ddcb26bced1ac6f529e
Source dataset
uspto-grants-2002_04
Patent number
US06380242B1

Reaction notes

Loading…